{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:46:58Z","timestamp":1791222418901,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s13402-014-0175-7","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T10:13:23Z","timestamp":1404468803000},"page":"167-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents - implications for cancer treatment and chemoprevention"],"prefix":"10.1007","volume":"37","author":[{"given":"Eugenia","family":"Yiannakopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,5]]},"reference":[{"key":"175_CR1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/03602530801952864","volume":"40","author":"D Nebert","year":"2008","unstructured":"D. Nebert, G. Zhang, E. Vesell, From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 40, 187\u2013224 (2008)","journal-title":"Drug Metab Rev"},{"key":"175_CR2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2217\/14622416.9.12.1879","volume":"9","author":"PK Lo","year":"2008","unstructured":"P.K. Lo, S. Sukumar, Epigenomics and breast cancer. Pharmacogenomics 9, 1879\u20131902 (2008)","journal-title":"Pharmacogenomics"},{"key":"175_CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13402-012-0085-5","volume":"35","author":"JG Mart\u00ednez","year":"2012","unstructured":"J.G. Mart\u00ednez, J. P\u00e9rez-Escuredo, P. Castro-Santos, C.A. Marcos, J.L. Pend\u00e1s, M.F. Fraga, Hermsen. M.A. Hypomethylation of LINE-1, and not centromeric SAT-\u03b1, is associated with centromeric instability in head and neck squamous cell carcinoma. Cell Oncol 35, 259\u201367 (2012)","journal-title":"Cell Oncol"},{"key":"175_CR4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s13402-012-0095-3","volume":"35","author":"S Babashah","year":"2012","unstructured":"S. Babashah, M. Sadeghizadeh, M.R. Tavirani, S. Farivar, Soleimani. M. Aberrant microRNA expression and its implications in the pathogenesis of leukemias. Cell Oncol 35, 317\u201334 (2012)","journal-title":"Cell Oncol"},{"key":"175_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13402-012-0122-4","volume":"36","author":"R Nagadia","year":"2013","unstructured":"R. Nagadia, P. Pandit, W.B. Coman, J. Cooper-White, C. Punyadeera, miRNAs in head and neck cancer revisited. Cell Oncol 36, 1\u20137 (2013)","journal-title":"Cell Oncol"},{"key":"175_CR6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxlet.2010.06.019","volume":"198","author":"C Lema","year":"2010","unstructured":"C. Lema, M. Cunningham, MicroRNAs and their implications in toxicological research. Toxicol Lett 198, 100\u2013105 (2010)","journal-title":"Toxicol Lett"},{"key":"175_CR7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4161\/cc.7.7.5666","volume":"7","author":"PJ Mishra","year":"2008","unstructured":"P.J. Mishra, P.J. Mishra, D. Barenjee, J.R. Bertino, MiRNSPs or MiR polymorphisms, new players in microRNA mediated regulation of the cell. Cell Cycle 7, 853\u2013858 (2008)","journal-title":"Cell Cycle"},{"key":"175_CR8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2217\/14622416.10.3.399","volume":"10","author":"PJ Mishra","year":"2009","unstructured":"P.J. Mishra, J.R. Bertino, MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and personalized medicine. Pharmacogenomics 10, 399\u2013416 (2009)","journal-title":"Pharmacogenomics"},{"key":"175_CR9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2217\/epi.10.51","volume":"6","author":"ED Wiklund","year":"2010","unstructured":"E.D. Wiklund, J. Kjems, S.J. Clark, Epigenetic architecture and miRNA: reciprocal regulators. Epigenomics 6, 823\u2013840 (2010)","journal-title":"Epigenomics"},{"key":"175_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13402-013-0140-x","volume":"36","author":"FA Duijkers","year":"2013","unstructured":"F.A. Duijkers, R.X. de Menezes, I.J. Goossens-Beumer, D.J. Stumpel, P. Admiraal, R. Pieters, J.P. Meijerink, M.M. van Noesel, Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines. Cell Oncol 36, 351\u201362 (2013)","journal-title":"Cell Oncol"},{"key":"175_CR11","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1158\/1078-0432.CCR-08-2783","volume":"15","author":"JP Issa","year":"2009","unstructured":"J.P. Issa, H.M. Kantarjian, Targeting DNA methylation Clin Cancer Res 15, 3938\u201346 (2009)","journal-title":"Targeting DNA methylation Clin Cancer Res"},{"key":"175_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/187152011795347513","volume":"11","author":"J Garc\u00eda-Quiroz","year":"2011","unstructured":"J. Garc\u00eda-Quiroz, J. Camacho, Astemizole: an old anti-histamine as a new promising anti-cancer drug. Anticancer Agents Med Chem 11, 307\u201314 (2011)","journal-title":"Anticancer Agents Med Chem"},{"key":"175_CR13","first-page":"1271","volume":"27","author":"C Zhao","year":"2012","unstructured":"C. Zhao, X. Bu, Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol Histopathol 27, 1271\u201382 (2012)","journal-title":"Histol Histopathol"},{"key":"175_CR14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s10552-010-9579-5","volume":"9","author":"TM Brasky","year":"2010","unstructured":"T.M. Brasky, M.R. Bonner, K.B. Moysich, C.B. Ambrosone, J. Nie, M.H. Tao, S.B. Edge, B.V. Kallakury, H.M. Ochs-Balcom, C. Marian, M. Trevisan, P.G. Shields, J.L. Freudenheim, Non steroidal anti-inflammatory drug use (NSAID) and breast cancer risk in the western New York exposures and breast cancer (WEB) study. Cancer Causes Control 9, 1503\u20131512 (2010)","journal-title":"Cancer Causes Control"},{"key":"175_CR15","doi-asserted-by":"crossref","unstructured":"Li, X.; Gao, L.; Cui, Q.; Gary, B.D.; Dyess, D.L.; Taylor, W.; Shevde, L.A.; Samant, R.S.; Dean-Colomb, W.; Piazza, G.A.; Xi, Y. Sulindac inhibits tumor cell invasion by suppressing NF-\u03baB-mediated transcription of microRNAs. Oncogene 31, 4979\u20134986 (2012)","DOI":"10.1038\/onc.2011.655"},{"key":"175_CR16","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1177\/0091270011431066","volume":"52","author":"E Yiannakopoulou","year":"2011","unstructured":"E. Yiannakopoulou, Modulation of lymphangiogenesis: a New target for aspirin and other Nonsteroidal anti-inflammatory agents? a systematic review. J Clin Pharmacol 52, 1749\u201354 (2011)","journal-title":"J Clin Pharmacol"},{"key":"175_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","volume":"191","author":"M Dovizio","year":"2013","unstructured":"M. Dovizio, A. Bruno, S. Tacconelli, P. Patrignani, Mode of action of aspirin as a chemopreventive agent. Recent Results Cancer Res 191, 39\u201365 (2013)","journal-title":"Recent Results Cancer Res"},{"key":"175_CR18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1034\/j.1600-0714.2002.00034.x","volume":"31","author":"J Worm","year":"2002","unstructured":"J. Worm, P. Guldberg, DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy. J Oral Pathol Med 31, 443\u20139 (2002)","journal-title":"J Oral Pathol Med"},{"key":"175_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.toxlet.2009.10.010","volume":"192","author":"J Paluszczak","year":"2010","unstructured":"J. Paluszczak, V. Krajka-Ku\u017aniak, W. Baer-Dubowska, The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett 192, 119\u2013125 (2010)","journal-title":"Toxicol Lett"},{"key":"175_CR20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.drudis.2011.02.003","volume":"16","author":"JL Medina-Franco","year":"2011","unstructured":"J.L. Medina-Franco, T. Caulfield, Advances in the computational development of DNA methyltransferase inhibitors. Drug Discov Today 16, 418\u2013425 (2011)","journal-title":"Drug Discov Today"},{"key":"175_CR21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bmc.2009.11.050","volume":"18","author":"D Kuck","year":"2010","unstructured":"D. Kuck, N. Singh, F. Lyko, J.L. Medina-Franco, Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. Bioorg Med Chem 18, 822\u2013829 (2010)","journal-title":"Bioorg Med Chem"},{"key":"175_CR22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00894-011-1191-4","volume":"18","author":"J Yoo","year":"2012","unstructured":"J. Yoo, J.L. Medina Franco, Trimethylaurintricarboxylic acid inhibits human DNA methyltransferase 1: insights from enzymatic and molecular modeling studies. J Mol Model 18, 1583\u20131589 (2012)","journal-title":"J Mol Model"},{"key":"175_CR23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3181\/0709-RM-257","volume":"233","author":"MR Pan","year":"2008","unstructured":"M.R. Pan, H.C. Chang, L.Y. Chuang, W.C. Hung, The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells. Exp Biol Med (Maywood) 233, 456\u2013462 (2008)","journal-title":"Exp Biol Med (Maywood)"},{"key":"175_CR24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10620-008-0701-4","volume":"55","author":"T Tahara","year":"2010","unstructured":"T. Tahara, T. Shibata, M. Nakamura, H. Yamashita, D. Yoshioka, M. Okubo, N. Maruyama, T. Kamano, Y. Kamiya, H. Fujita, M. Nagasaka, M. Iwata, K. Takahama, M. Watanabe, I. Hirata, T. Arisawa, Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa. Dig Dis Sci 55, 54\u20139 (2010)","journal-title":"Dig Dis Sci"},{"key":"175_CR25","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1349-7006.2009.01175.x","volume":"100","author":"T Tahara","year":"2009","unstructured":"T. Tahara, T. Shibata, H. Yamashita, M. Nakamura, D. Yoshioka, M. Okubo, I. Hirata, T. Arisawa, Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa. Cancer Sci 100, 1192\u20131197 (2009)","journal-title":"Cancer Sci"},{"key":"175_CR26","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ijc.24467","volume":"125","author":"ML Slattery","year":"2009","unstructured":"M.L. Slattery, R.K. Wolff, J. Herrick, B.J. Caan, W. Samowitz, Tumor markers and rectal cancer: support for an inflammation-related pathway. Int J Cancer 125, 1698\u20131704 (2009)","journal-title":"Int J Cancer"},{"key":"175_CR27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ijc.22342","volume":"120","author":"ML Slattery","year":"2007","unstructured":"M.L. Slattery, K. Curtin, C. Sweeney, T.R. Levin, J. Potter, R.K. Wolff, H. Albertsen, W.S. Samowitz, Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 120, 656\u2013663 (2007)","journal-title":"Int J Cancer"},{"key":"175_CR28","first-page":"545","volume":"99","author":"EI Heath","year":"2007","unstructured":"E.I. Heath, M.I. Canto, S. Piantadosi, E. Montgomery, W.M. Weinstein, J.G. Herman, A.J. Dannenberg, V.W. Yang, A.O. Shar, E. Hawk, A.A. Forastiere, Chemoprevention for Barrett\u2019s esophagus trial research group. Secondary chemoprevention of Barrett\u2019s esophagus with celecoxib: results of a randomized trial. J. Natl. Cancer Risk 99, 545\u2013557 (2007)","journal-title":"Cancer Risk"},{"key":"175_CR29","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1158\/1940-6207.CAPR-10-0047","volume":"3","author":"K Wallace","year":"2010","unstructured":"K. Wallace, M.V. Grau, A.J. Levine, L. Shen, R. Hamdan, X. Chen, J. Gui, R.W. Haile, E.L. Barry, D. Ahnen, G. McKeown-Eyssen, J.A. Baron, J.P. Issa, Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila) 3, 1552\u20131564 (2010)","journal-title":"Cancer Prev Res (Phila)"},{"key":"175_CR30","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1158\/1055-9965.EPI-08-0926","volume":"18","author":"JC Figueiredo","year":"2009","unstructured":"J.C. Figueiredo, M.V. Grau, K. Wallace, A.J. Levine, L. Shen, R. Hamdan, X. Chen, R.S. Bresalier, G. McKeown-Eyssen, R.W. Haile, J.A. Baron, J.P. Issa, Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 18, 1041\u20131049 (2009)","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"175_CR31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mc.20003","volume":"39","author":"L Tao","year":"2004","unstructured":"L. Tao, W. Wang, P.M. Kramer, R.A. Lubet, V.E. Steele, M.A. Pereira, Modulation of DNA hypomethylation as a surrogate endpoint biomarker for chemoprevention, of colon cancer. Mol Carcinogen 39, 79\u2013842 (2004)","journal-title":"Mol Carcinogen"},{"key":"175_CR32","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/carcin\/bgh209","volume":"25","author":"MA Pereira","year":"2004","unstructured":"M.A. Pereira, L. Tao, W. Wang, Y. Li, A. Umar, V.E. Steele, Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors. Carcinogenesis 25, 1917\u20131923 (2004)","journal-title":"Carcinogenesis"},{"key":"175_CR33","first-page":"21","volume":"2","author":"R Shen","year":"2009","unstructured":"R. Shen, L. Tao, Y. Xu, S. Chang, J. Van Brocklyn, J.X. Gao, Reversibility of aberrant global DNA and estrogen receptor-alpha gene methylation distinguishes colorectal precancer from cancer. Int J Clin Exp Pathol 2, 21\u201323 (2009)","journal-title":"Int J Clin Exp Pathol"},{"key":"175_CR34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/1087057111417871","volume":"16","author":"RM Eglen","year":"2011","unstructured":"R.M. Eglen, T. Reisine, Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview. J Biomol Screen 16, 1137\u20131152 (2011)","journal-title":"J Biomol Screen"},{"key":"175_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.biocel.2008.08.020","volume":"41","author":"A Mai","year":"2009","unstructured":"A. Mai, L. Altucci, Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead. Int J Biochem Cell Biol 41, 199\u2013213 (2009)","journal-title":"Int J Biochem Cell Biol"},{"key":"175_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejphar.2012.11.051","volume":"699","author":"P Kamble","year":"2013","unstructured":"P. Kamble, K. Selvarajan, C. Aluganti Narasimhulu, M. Nandave, S. Parthasarathy, Aspirin may promote mitochondrial biogenesis via the production of hydrogen peroxide and the induction of Sirtuin1\/PGC-1\u03b1 genes. Eur J Pharmacol 699, 55\u201361 (2013)","journal-title":"Eur J Pharmacol"},{"key":"175_CR37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/toxsci\/kfn094","volume":"104","author":"F Renzo Di","year":"2008","unstructured":"F. Di Renzo, G. Cappelletti, M.L. Broccia, E. Giavini, E. Menegola, The inhibition of embryonic histone deacetylases as the possible mechanism accounting for axial skeletal malformations induced by sodium salicylate. Toxicol Sci 104, 397\u2013404 (2008)","journal-title":"Toxicol Sci"},{"key":"175_CR38","first-page":"219","volume":"20","author":"J Sonnemann","year":"2008","unstructured":"J. Sonnemann, I. H\u00fcls, M. Sigler, C.D. Palani, T.T. le Hong, U. V\u00f6lker, H.K. Kroemer, J.F. Beck, Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells. Oncol Rep 20, 219\u2013224 (2008)","journal-title":"Oncol Rep"},{"key":"175_CR39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cellsig.2011.09.025","volume":"24","author":"K Deckmann","year":"2012","unstructured":"K. Deckmann, F. R\u00f6rsch, G. Geisslinger, S. Gr\u00f6sch, Dimethylcelecoxib induces an inhibitory complex consisting of HDAC1\/NF-\u03baB(p65)RelA leading to transcriptional downregulation of mPGES-1 and EGR1. Cell Signal 24, 460\u2013467 (2012)","journal-title":"Cell Signal"},{"key":"175_CR40","doi-asserted-by":"crossref","first-page":"33129","DOI":"10.1074\/jbc.M805248200","volume":"283","author":"H Yoshioka","year":"2008","unstructured":"H. Yoshioka, T. Watanabe, T.E. Eling, Nonsteroidal anti-inflammatory drug-activated gene (NAG-1\/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A. J Biol Chem 283, 33129\u201333137 (2008)","journal-title":"J Biol Chem"},{"key":"175_CR41","first-page":"1273","volume":"39","author":"S Marimuthu","year":"2011","unstructured":"S. Marimuthu, R.S. Chivukula, L.F. Alfonso, M. Moridani, F.K. Hagen, G.J. Bhat, Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: Identification of novel targets. Int J Oncol 39, 1273\u20131283 (2011)","journal-title":"Int J Oncol"},{"key":"175_CR42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.110.222968","volume":"107","author":"SB Jung","year":"2010","unstructured":"S.B. Jung, C.S. Kim, A. Naqvi, T. Yamamori, I. Mattagajasingh, T.A. Hoffman, M.P. Cole, A. Kumar, J.S. Dericco, B.H. Jeon, K. Irani, Histone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase. Circ Res 107, 877\u201387 (2010)","journal-title":"Circ Res"},{"key":"175_CR43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11670-012-0264-y","volume":"24","author":"J Tan","year":"2012","unstructured":"J. Tan, B. Chen, L. He, Y. Tang, Z. Jiang, G. Yin, J. Wang, X. Jiang, Anacardic acid (6-pentadecylsalicylic acid) induces apoptosis of prostate cancer cells through inhibition of androgen receptor and activation of p53 signaling. Chin J Cancer Res 24, 275\u201383 (2012)","journal-title":"Chin J Cancer Res"},{"key":"175_CR44","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1182\/blood-2007-10-117994","volume":"111","author":"B Sung","year":"2008","unstructured":"B. Sung, M.K. Pandey, K.S. Ahn, T. Yi, M.M. Chaturvedi, M. Liu, B.B. Aggarwal, Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 111, 4880\u20134891 (2008)","journal-title":"Blood"},{"key":"175_CR45","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.febslet.2006.06.092","volume":"580","author":"Y Sun","year":"2006","unstructured":"Y. Sun, X. Jiang, S. Chen, B.D. Price, Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation. FEBS Lett 580, 4353\u20134356 (2006)","journal-title":"FEBS Lett"},{"key":"175_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2012.06.010","volume":"53","author":"Y Kim","year":"2013","unstructured":"Y. Kim, K. Kim, D. Park, E. Lee, H. Lee, Y.S. Lee, J. Choe, Y.M. Kim, D. Jeoung, DNA methyl transferase I acts as a negative regulator of allergic skin inflammation. Mol Immunol 53, 1\u201314 (2013)","journal-title":"Mol Immunol"},{"key":"175_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4161\/cib.1.2.6997","volume":"1","author":"A Koornneef","year":"2008","unstructured":"A. Koornneef, K. Rindermann, C. Gatz, C.M. Pieterse, Histone modifications do not play a major role in salicylate-mediated suppression of jasmonate-induced PDF1.2 gene expression. Commun Integr Biol 1, 143\u20135 (2008)","journal-title":"Commun Integr Biol"},{"key":"175_CR48","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.4161\/cc.5.15.3100","volume":"5","author":"T Tanaka","year":"2006","unstructured":"T. Tanaka, A. Kurose, H.D. Halicka, X. Huang, F. Traganos, Z. Darzynkiewicz, Nitrogen oxide-releasing aspirin induces histone H2AX phosphorylation, ATM activation and apoptosis preferentially in S-phase cells: involvement of reactive oxygen species. Cell Cycle 5, 1669\u201374 (2006)","journal-title":"Cell Cycle"},{"key":"175_CR49","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/ol.2010.173","volume":"1","author":"M Yanokura","year":"2010","unstructured":"M. Yanokura, K. Banno, Y. Kobayashi, I. Kisu, A. Ueki, A. Ono, K. Masuda, H. Nomura, A. Hirasawa, N. Susumu, D. Aoki, MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review). Oncol Lett 1, 935\u2013940 (2010)","journal-title":"Oncol Lett"},{"key":"175_CR50","first-page":"519","volume":"40","author":"F Lan","year":"2012","unstructured":"F. Lan, X. Yue, L. Han, Z. Shi, Y. Yang, P. Pu, Z. Yao, C. Kang, Genome-wide identification of TCF7L2\/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer. Int J Oncol 40, 519\u2013526 (2012)","journal-title":"Int J Oncol"},{"key":"175_CR51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.canlet.2008.06.034","volume":"272","author":"Y Chen","year":"2008","unstructured":"Y. Chen, W. Liu, T. Chao, Y. Zhang, X. Yan, Y. Gong, B. Qiang, J. Yuan, M. Sun, X. Peng, MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett 272, 197\u2013205 (2008)","journal-title":"Cancer Lett"},{"key":"175_CR52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","volume":"133","author":"F Meng","year":"2007","unstructured":"F. Meng, R. Henson, H. Wehbe-Janek, K. Ghoshal, S.T. Jacob, T. Patel, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647\u2013658 (2007)","journal-title":"Gastroenterology"},{"key":"175_CR53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2009.08.044","volume":"388","author":"Q Yao","year":"2009","unstructured":"Q. Yao, H. Xu, Q.Q. Zhang, H. Zhou, L.H. Qu, MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun 388, 539\u2013542 (2009)","journal-title":"Biochem Biophys Res Commun"},{"key":"175_CR54","doi-asserted-by":"crossref","unstructured":"Sicard, F.; Gayral, M.; Lulka, H.; Buscail, L.; Cordelier, P. Targeting miR-21 for the Therapy of Pancreatic Cancer. Mol Ther, 2013, doi: 10.1038\/mt.2013.35","DOI":"10.1038\/mt.2013.35"},{"key":"175_CR55","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ijc.27862","volume":"132","author":"Y Saito","year":"2013","unstructured":"Y. Saito, H. Suzuki, H. Imaeda, J. Matsuzaki, K. Hirata, H. Tsugawa, S. Hibino, Y. Kanai, H. Saito, T. Hibi, The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. Int J Cancer 132, 1751\u20131760 (2013)","journal-title":"Int J Cancer"},{"key":"175_CR56","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3892\/etm.2012.531","volume":"3","author":"WC Chen","year":"2012","unstructured":"W.C. Chen, M.S. Lin, Y.L. Ye, H.J. Gao, Z.Y. Song, X.Y. Shen, microRNA expression pattern and its alteration following celecoxib intervention in human colorectal cancer. Exp Ther Med 3, 1039\u20131048 (2012)","journal-title":"Exp Ther Med"},{"key":"175_CR57","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1002\/jcb.24167","volume":"113","author":"J Tan","year":"2012","unstructured":"J. Tan, L. Fan, J.J. Mao, B. Chen, L. Zheng, T. Zhang, T. Li, J. Duan, Y. Duan, Z. Jin, W. Kuang, Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NF\u03baB activity. J Cell Biochem 113, 2903\u20138 (2012)","journal-title":"J Cell Biochem"},{"key":"175_CR58","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1158\/1535-7163.MCT-07-0159","volume":"6","author":"ED Eliseeva","year":"2007","unstructured":"E.D. Eliseeva, V. Valkov, M. Jung, M.O. Jung, Characterization of novel inhibitors of histone acetyltransferases. Mol Cancer Ther 6, 2391\u20132398 (2007)","journal-title":"Mol Cancer Ther"},{"key":"175_CR59","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/ars.2010.3492","volume":"15","author":"AR Cyr","year":"2011","unstructured":"A.R. Cyr, F.E. Domann, The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid Redox Signal 15, 551\u2013589 (2011)","journal-title":"Antioxid Redox Signal"},{"key":"175_CR60","doi-asserted-by":"crossref","first-page":"E2183","DOI":"10.1073\/pnas.1209329109","volume":"109","author":"RH Dowen","year":"2012","unstructured":"R.H. Dowen, M. Pelizzola, R.J. Schmitz, R. Lister, J.M. Dowen, J.R. Nery, J.E. Dixon, J.R. Ecker, Widespread dynamic DNA methylation in response to biotic stress. Proc Natl Acad Sci U S A 109, E2183\u2013E2191 (2012)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"175_CR61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bpg.2011.10.016","volume":"25","author":"K Schr\u00f6r","year":"2011","unstructured":"K. Schr\u00f6r, Pharmacology and cellular\/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best Pract Res Clin Gastroenterol 25, 473\u2013484 (2011)","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"175_CR62","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2672.2008.04061.x","volume":"106","author":"EC Yiannakopoulou","year":"2009","unstructured":"E.C. Yiannakopoulou, E. Tiligada, Protective effect of salicylates against hydrogen peroxide stress in yeast. J Appl Microbiol 106, 903\u2013908 (2009)","journal-title":"J Appl Microbiol"},{"key":"175_CR63","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.37806","volume":"65","author":"MC Andr\u00e9s de","year":"2013","unstructured":"M.C. de Andr\u00e9s, K. Imagawa, K. Hashimoto, A. Gonzalez, H.I. Roach, M.B. Goldring, R.O. Oreffo, Loss of methylation in CpG sites in the NF-\u03baB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. Arthritis Rheum 65, 732\u2013742 (2013)","journal-title":"Arthritis Rheum"},{"key":"175_CR64","doi-asserted-by":"crossref","unstructured":"Fata, J.E.; Debnath, S.; Jenkins, E.C. Jr; Fournier, M.V. Nongenomic Mechanisms of PTEN Regulation. Int. J. Cell Biol., 2012, 379685","DOI":"10.1155\/2012\/379685"},{"key":"175_CR65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1160\/TH06-07-0403","volume":"96","author":"KK Wu","year":"2006","unstructured":"K.K. Wu, Transcription-based COX-2 inhibition: a therapeutic strategy. Thromb Haemost 96, 417\u2013422 (2006)","journal-title":"Thromb Haemost"},{"key":"175_CR66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-3-642-30331-9_2","volume":"191","author":"DA Dixon","year":"2013","unstructured":"D.A. Dixon, F.F. Blanco, A. Bruno, P. Patrignani, Mechanistic aspects of COX-2 expression in colorectal neoplasia. Recent Results Cancer Res 191, 7\u201337 (2013)","journal-title":"Recent Results Cancer Res"},{"key":"175_CR67","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1002\/cncr.25414","volume":"116","author":"S Fu","year":"2010","unstructured":"S. Fu, R. Kurzrock, Development of curcumin as an epigenetic agent. Cancer 116, 4670\u20134676 (2010)","journal-title":"Cancer"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-014-0175-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-014-0175-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-014-0175-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T11:47:36Z","timestamp":1565610456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-014-0175-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["175"],"URL":"https:\/\/doi.org\/10.1007\/s13402-014-0175-7","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}